WallStreetZenWallStreetZen

NASDAQ: EOLS
Evolus Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for EOLS

Based on 2 analysts offering 12 month price targets for Evolus Inc

Min Forecast
$13.00+46.4%
Avg Forecast
$13.00+46.4%
Max Forecast
$13.00+46.4%

Should I buy or sell EOLS stock?

Based on 2 analysts offering ratings for Evolus Inc.

Strong Buy
Strong Buy
1 analysts 50%
Buy
1 analysts 50%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Our proven Zen Rating quant model "Buy" agrees with analyst consensus with a "Strong Buy" rating. Learn More

Be the first to know when Wall Street analysts revise their EOLS stock forecasts and price targets.

EOLS stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2026-08-25
lockedlocked$00.00+00.00%2026-06-17

1 of 1

Forecast return on equity

Is EOLS forecast to generate an efficient return?

Company
-268.15%
Industry
62.34%
Market
167.66%
EOLS's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is EOLS forecast to generate an efficient return on assets?

Company
33.41%
Industry
23.61%
EOLS is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

EOLS earnings per share forecast

What is EOLS's earnings per share in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
-$0.13
Avg 2 year Forecast
$0.24
Avg 3 year Forecast
$0.65

EOLS revenue forecast

What is EOLS's revenue in the next 3 years based on estimates from 9 analysts?

Avg 1 year Forecast
$341.0M+7.76%
Avg 2 year Forecast
$399.3M+26.15%
Avg 3 year Forecast
$471.0M+48.81%
EOLS's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

EOLS revenue growth forecast

How is EOLS forecast to perform vs Drug Manufacturers - Specialty & Generic companies and vs the US market?

Company
13.99%
Industry
10.53%
Market
13.42%
EOLS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
EOLS's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

EOLS vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
EOLS$8.88$13.00+46.40%Strong Buy
TLRY$4.59$7.50+63.40%Strong Buy
AQST$5.02$10.00+99.20%Buy
EVO$1.91N/AN/A
IRWD$4.13N/AN/A
View Top Pharmaceutical Stocks

Evolus Stock Forecast FAQ

Is Evolus Stock a good buy in 2026, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: EOLS) stock is to Strong Buy EOLS stock.

Out of 2 analysts, 1 (50%) are recommending EOLS as a Strong Buy, 1 (50%) are recommending EOLS as a Buy, 0 (0%) are recommending EOLS as a Hold, 0 (0%) are recommending EOLS as a Sell, and 0 (0%) are recommending EOLS as a Strong Sell.

If you're new to stock investing, here's how to buy Evolus stock.

What is EOLS's earnings growth forecast for 2026-2028?

(NASDAQ: EOLS) Evolus's forecast annual earnings growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast earnings growth rate of 18.39%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 30.99%.

Evolus's earnings in 2026 is -$34,333,000.On average, 9 Wall Street analysts forecast EOLS's earnings for 2026 to be -$8,758,288, with the lowest EOLS earnings forecast at -$30,422,833, and the highest EOLS earnings forecast at -$1,387,059. On average, 9 Wall Street analysts forecast EOLS's earnings for 2027 to be $15,607,719, with the lowest EOLS earnings forecast at -$5,178,354, and the highest EOLS earnings forecast at $32,595,892.

In 2028, EOLS is forecast to generate $43,230,013 in earnings, with the lowest earnings forecast at $20,713,418 and the highest earnings forecast at $58,950,018.

What is EOLS's revenue growth forecast for 2026-2028?

(NASDAQ: EOLS) Evolus's forecast annual revenue growth rate of 13.99% is forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of 10.53%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.42%.

Evolus's revenue in 2026 is $316,488,000.On average, 9 Wall Street analysts forecast EOLS's revenue for 2026 to be $22,525,842,058, with the lowest EOLS revenue forecast at $21,554,900,590, and the highest EOLS revenue forecast at $23,295,990,188. On average, 9 Wall Street analysts forecast EOLS's revenue for 2027 to be $26,371,298,674, with the lowest EOLS revenue forecast at $24,137,472,794, and the highest EOLS revenue forecast at $27,975,663,862.

In 2028, EOLS is forecast to generate $31,107,115,222 in revenue, with the lowest revenue forecast at $27,924,144,519 and the highest revenue forecast at $33,772,910,981.

What is EOLS's forecast return on assets (ROA) for 2026-2029?

(NASDAQ: EOLS) forecast ROA is 33.41%, which is higher than the forecast US Drug Manufacturers - Specialty & Generic industry average of 23.61%.

What is EOLS's Price Target?

According to 2 Wall Street analysts that have issued a 1 year EOLS price target, the average EOLS price target is $13.00, with the highest EOLS stock price forecast at $13.00 and the lowest EOLS stock price forecast at $13.00.

On average, Wall Street analysts predict that Evolus's share price could reach $13.00 by Aug 25, 2027. The average Evolus stock price prediction forecasts a potential upside of 46.4% from the current EOLS share price of $8.88.

What is EOLS's Earnings Per Share (EPS) forecast for 2026-2028?

(NASDAQ: EOLS) Evolus's current Earnings Per Share (EPS) is -$0.52. On average, analysts forecast that EOLS's EPS will be -$0.13 for 2026, with the lowest EPS forecast at -$0.46, and the highest EPS forecast at -$0.02. On average, analysts forecast that EOLS's EPS will be $0.24 for 2027, with the lowest EPS forecast at -$0.08, and the highest EPS forecast at $0.49. In 2028, EOLS's EPS is forecast to hit $0.65 (min: $0.31, max: $0.89).

What is EOLS's forecast return on equity (ROE) for 2026-2029?

(NASDAQ: EOLS) forecast ROE is -268.15%, which is considered weak.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.